Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$697M |
| 2 |
Alibaba
BABA
|
+$410M |
| 3 |
T-Mobile US
TMUS
|
+$310M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$230M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$163M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$723M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$700M |
| 3 |
iShares Floating Rate Bond ETF
FLOT
|
+$700M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$538M |
| 5 |
Amazon
AMZN
|
+$461M |
Sector Composition
| 1 | Technology | 9.62% |
| 2 | Consumer Discretionary | 8.78% |
| 3 | Communication Services | 6.04% |
| 4 | Healthcare | 5.47% |
| 5 | Industrials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Direxion Daily MSCI India Bull 2X Shares
INDL
$70.1M
| $892K | ﹤0.01% |
43,347
+15,824
| +57% | +$326K |
|
2027
Omnicom Group
OMC
$14.8B
| $892K | ﹤0.01% |
16,336
-20,750
| -56% | -$1.13M |
|
2028
VanEck Oil Refiners ETF
CRAK
$27.8M
| $891K | ﹤0.01% |
41,021
+24,184
| +144% | +$525K |
|
2029
Bio-Techne
TECH
$8.01B
| $886K | ﹤0.01% |
+13,420
| New | +$886K |
|
|
LMNX
2030
DELISTED
Luminex Corp
LMNX
| $884K | ﹤0.01% |
+27,187
| New | +$884K |
|
|
KFYP
2031
DELISTED
KraneShares CICC China Leaders 100 Index ETF
KFYP
| $883K | ﹤0.01% |
33,948
-2,263
| -6% | -$58.9K |
|
2032
IQ Candriam US Large Cap Equity ETF
IQSU
$262M
| $881K | ﹤0.01% |
33,578
-1,440
| -4% | -$37.8K |
|
2033
Smith & Nephew
SNN
$16.2B
| $881K | ﹤0.01% |
+23,600
| New | +$881K |
|
2034
Cardlytics
CDLX
$76.1M
| $880K | ﹤0.01% |
12,572
+6,797
| +118% | +$476K |
|
2035
Gen Digital
GEN
$17.7B
| $880K | ﹤0.01% |
44,383
-38,011
| -46% | -$754K |
|
2036
UMB Financial
UMBF
$9.15B
| $880K | ﹤0.01% |
+17,066
| New | +$880K |
|
2037
WisdomTree US MidCap Dividend Fund
DON
$3.79B
| $878K | ﹤0.01% |
30,995
-27,508
| -47% | -$779K |
|
|
KALL
2038
DELISTED
KraneShares MSCI All China Index ETF
KALL
| $876K | ﹤0.01% |
32,531
-7,612
| -19% | -$205K |
|
|
CHNA
2039
DELISTED
Loncar China BioPharma ETF
CHNA
| $876K | ﹤0.01% |
28,493
-28,891
| -50% | -$888K |
|
2040
VanEck Morningstar International Moat ETF
MOTI
$196M
| $874K | ﹤0.01% |
30,959
-47,214
| -60% | -$1.33M |
|
2041
VanEck Brazil Small-Cap ETF
BRF
$22.4M
| $873K | ﹤0.01% |
52,310
-3,916
| -7% | -$65.4K |
|
2042
Brookfield Infrastructure Partners
BIP
$14.2B
| $872K | ﹤0.01% |
31,859
-66,408
| -68% | -$1.82M |
|
2043
FlexShares Credit-Scored US Corporate Bond Index Fund
SKOR
$570M
| $872K | ﹤0.01% |
15,980
-169,127
| -91% | -$9.23M |
|
|
SA
2044
Seabridge Gold
SA
$1.96B
| $871K | ﹤0.01% |
49,624
-28,371
| -36% | -$498K |
|
2045
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$18.7B
| $870K | ﹤0.01% |
10,666
+1,926
| +22% | +$157K |
|
2046
NewMarket
NEU
$7.81B
| $870K | ﹤0.01% |
2,173
-62
| -3% | -$24.8K |
|
2047
Arrowhead Research
ARWR
$4.03B
| $868K | ﹤0.01% |
20,107
+12,826
| +176% | +$554K |
|
2048
International Paper
IP
$24.8B
| $868K | ﹤0.01% |
26,031
-291,284
| -92% | -$9.71M |
|
2049
Lineage Cell Therapeutics
LCTX
$317M
| $867K | ﹤0.01% |
996,255
+806,304
| +424% | +$702K |
|
2050
News Corp Class A
NWSA
$17B
| $866K | ﹤0.01% |
73,010
+54,984
| +305% | +$652K |
|